← Back to headlines
Nektar Therapeutics Files Nasdaq Inducement Grant Disclosure
Nektar Therapeutics announced equity inducement grants issued under Nasdaq Listing Rule 5635(c)(4) to attract and retain key employees and directors.
28 Aug, 20:33 — 28 Aug, 20:33
Sources
Showing 1 of 1 sources
